SCHEMBL12373462

SCHEMBL12373462

CCn1c(C(C)NS(=O)(=O)c2ccc(C(C)=O)cc2)cnc1Oc1ccc(C)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADAMTS4 O75173 2/20 0.43
GFER P55789 1/20 0.41
HPGD P15428 2/20 0.41
MAPT P10636 1/20 0.41
MMP13 P45452 2/20 0.40
KMT2A Q03164 2/20 0.39
GAA P10253 1/20 0.39
S1PR1 P21453 6/20 0.39
MMP2 P08253 1/20 0.38
MMP14 P50281 1/20 0.38
ADAMTS5 Q9UNA0 1/20 0.38
SLC1A3 P43003 1/20 0.38
SLC1A2 P43004 1/20 0.38
SLC1A1 P43005 1/20 0.38
ALDH1A1 P00352 2/20 0.38
HSD17B10 Q99714 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
MEN1 O00255 1/20 0.38
LMNA P02545 1/20 0.38
ALOX12 P18054 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12373517 0.92 S1PR1 (0.44) MMP13KMT2AS1PR1ALDH1A1
SCHEMBL4119410 0.89 CNR1 (0.47) MMP13S1PR1MMP2ALDH1A1MMP9
SCHEMBL12373743 0.89 SMN1; SMN2 (0.41) ADAMTS4MMP13KMT2AS1PR1MMP2
SCHEMBL12373461 0.89 MAPT (0.50) ADAMTS4GFERMAPTKMT2AGAA
SCHEMBL12373499 0.88 S1PR1 (0.41) MMP13KMT2AS1PR1
SCHEMBL12373577 0.88 FFAR1 (0.47) ADAMTS4MAPTMMP13S1PR1MMP2
SCHEMBL12373463 0.88 MMP13 (0.41) MMP13S1PR1ALDH1A1MMP9
SCHEMBL12373495 0.87 S1PR1 (0.43) ADAMTS4S1PR1
SCHEMBL12373509 0.87 S1PR1 (0.41) MMP13KMT2AS1PR1
SCHEMBL12373473 0.87 S1PR1 (0.53) KMT2AS1PR1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7994204-B2 Binding inhibitor of sphingosine-1-phosphate TAISHO PHARMACEUTICAL CO., LTD (JP) 2011-08-09 US disclosed
US-7994204-B2 Binding inhibitor of sphingosine-1-phosphate TAISHO PHARMACEUTICAL CO., LTD (JP) 2011-08-09 US disclosed
US-20090182144-A1 BINDING INHIBITOR OF SPHINGOSINE-1-PHOSPHATE TAISHO PHARMACEUTICAL CO., LTD. (JP) 2009-07-16 US disclosed
US-20090182144-A1 BINDING INHIBITOR OF SPHINGOSINE-1-PHOSPHATE TAISHO PHARMACEUTICAL CO., LTD. (JP) 2009-07-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090182144-A1 BINDING INHIBITOR OF SPHINGOSINE-1-PHOSPHATE S1PR1, S1PR3, S1PR2 ADAMTS4 3922/4885GFER 3428/4885HPGD 2547/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.